← Evidence map

TrialBritish journal of cancer2026

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.

Anderley Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial. | OpenQuestion